DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elspar (Asparaginase) - News

 
 



News related to Elspar (Asparaginase) and/or conditions it is approved for

Killing leukemia cells by disrupting their metabolism doesn't harm normal cells
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.15]
A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts.

Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.12]
More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat...

Leukemia patients to benefit from novel cancer drug
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.11]
Results of a Phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy.

Gene network identified that is behind untreatable leukemia; discovery suggests possible treatment target
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.08]
Researchers have identified a genetic/molecular network that fuels a high-risk and aggressive form of Acute Myeloid Leukemia (AML) and its precursor disease Myelodysplastic Syndrome (MDS) - providing...

Researchers uncover genetic network that 'fuels' aggressive form of leukemia
Source: Blood / Hematology News From Medical News Today [2014.09.05]
Researchers have discovered a genetic network that fuels an aggressive form of leukemia and its precursor disease, MDS, opening the door to new treatments for the conditions.

Leukemia and other cancers could be treated more effectively with drug used for DNA repair defects
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.27]
A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore...

Hospital Admission Day Tied to Outcomes for Children With Leukemia
Source: MedicineNet Leukemia Specialty [2014.08.26]
Title: Hospital Admission Day Tied to Outcomes for Children With Leukemia
Category: Health News
Created: 8/25/2014 4:35:00 PM
Last Editorial Review: 8/26/2014 12:00:00 AM

Weekend hospitalization linked to longer stay for pediatric leukemia patients
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.25]
Weekend admission to the hospital for pediatric patients newly diagnosed with leukemia was associated with a longer length of stay, slightly longer wait to start chemotherapy and higher risk for...

Blueprint for the next generation of chronic myeloid leukemia treatment
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.21]
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have identified and characterized mutated forms of the gene that encodes BCR-ABL, the unregulated enzyme driving the blood...

Multiplying immune-system cells to battle pediatric leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.21]
Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells...

Dasatinib, a leukemia drug, has the potential to treat many cancers
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.21]
A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.

FDA Expands Use of Imbruvica for Form of Leukemia
Source: MedicineNet Leukemia Specialty [2014.07.29]
Title: FDA Expands Use of Imbruvica for Form of Leukemia
Category: Health News
Created: 7/28/2014 4:35:00 PM
Last Editorial Review: 7/29/2014 12:00:00 AM

Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Source: MedicineNet Leukemia Specialty [2014.06.09]
Title: Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Category: Health News
Created: 6/6/2014 12:35:00 PM
Last Editorial Review: 6/9/2014 12:00:00 AM

Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Source: Compliance News From Medical News Today [2014.06.04]
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse...

Leukemia
Source: MedicineNet Carpal Tunnel Syndrome Specialty [2014.03.14]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/14/2014 12:00:00 AM

New Drug Combo Might Help Older, Sicker Patients With Leukemia
Source: MedicineNet rituximab Specialty [2014.01.10]
Title: New Drug Combo Might Help Older, Sicker Patients With Leukemia
Category: Health News
Created: 1/9/2014 2:35:00 PM
Last Editorial Review: 1/10/2014 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

Idelalisib (Zydelig) Approved in Europe
Source: Medscape Hematology-Oncology Headlines [2014.09.19]
The first-in-class oral agent is now approved in the EU for the treatment of chronic lymphocytic leukemia and follicular lymphoma.
International Approvals

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014